Jin Cai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jin Cai has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
Min Ji
School of Biological Science & Medical Engineering, Southeast University, Nanjing 210096, PR China
6 shared publications- Min Ji
State Key Laboratory of Bioelectronics, Jiangsu Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing, China
3 shared publications Xixi Chen
School of Chemistry and Chemical Engineering, Southeast University, Nanjing, Jiangsu 211189, PR China
3 shared publicationsYuhong Wang
School of Chemistry and Chemical Engineering, Southeast University, Nanjing, Jiangsu 211189, PR China
3 shared publicationsBenhua Zhou
School of Chemistry and Chemical Engineering Southeast University Nanjing Jiangsu China
2 shared publicationsBo Chen
Southeast University
2 shared publications
Latest Publications
- 19 February 2025
- Published by Elsevier in Bioorganic Chemistry
- Vol. 157, 108278
Design, synthesis and anti-tumor activity of BTK inhibitor Orelabrutinib derivatives
- 19 February 2025
- Published by Elsevier in Bioorganic Chemistry
- Vol. 157, 108278
Design, synthesis and anti-tumor activity of BTK inhibitor Orelabrutinib derivatives
- 4 April 2024
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 105, 129726
Design, synthesis and activity evaluation of quinolinone derivatives as EZH2 inhibitors
- 4 April 2024
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 105, 129726
Design, synthesis and activity evaluation of quinolinone derivatives as EZH2 inhibitors
- 29 September 2022
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 76, 129011
Design, synthesis and activity evaluation of Hedgehog inhibitor Itraconazole derivatives in A549 cells
- 29 September 2022
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 76, 129011
Design, synthesis and activity evaluation of Hedgehog inhibitor Itraconazole derivatives in A549 cells
- 11 February 2022
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 99 (4) , 634-649
New class of benzothiophene morpholine analogues with high selectivity and affinity were designed and evaluated for anti‐drug addiction
To probe the mechanism of dopamine receptors in drug addiction and look for potential new methods for treating this disease, we have designed and synthesized benzothiophene morpholine analogues that were considered as dopamine D3 receptor‐selective ligands. Radioligand binding assay was used to determine the binding affinity of target compounds. Members of this class have great selectivity and binding affinity in D3 receptor. In addition, the ability of these compounds to mitigate the symptoms of addiction from opioids was investigated in animal behavior patterns, and we have found that two compounds (18a and 18d) have good affinity in the D3R and exhibit the efficacy of anti‐drug addiction in morphine‐dependent mice induced by naloxone.
- 11 February 2022
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 99 (4) , 634-649
New class of benzothiophene morpholine analogues with high selectivity and affinity were designed and evaluated for anti‐drug addiction
To probe the mechanism of dopamine receptors in drug addiction and look for potential new methods for treating this disease, we have designed and synthesized benzothiophene morpholine analogues that were considered as dopamine D3 receptor‐selective ligands. Radioligand binding assay was used to determine the binding affinity of target compounds. Members of this class have great selectivity and binding affinity in D3 receptor. In addition, the ability of these compounds to mitigate the symptoms of addiction from opioids was investigated in animal behavior patterns, and we have found that two compounds (18a and 18d) have good affinity in the D3R and exhibit the efficacy of anti‐drug addiction in morphine‐dependent mice induced by naloxone.
- 1 August 2019
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 29 (16) , 2168-2172
Design, synthesis and biological evaluation of hypolipidemic compounds based on BRD4 inhibitor RVX-208
- 1 August 2019
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 29 (16) , 2168-2172
Design, synthesis and biological evaluation of hypolipidemic compounds based on BRD4 inhibitor RVX-208
- 1 June 2019
- Published by Elsevier in Bioorganic Chemistry
- Vol. 87, 720-727
Design, synthesis and evaluation of a novel metal chelator as multifunctional agents for the treatment of Alzheimer’s disease
- 1 June 2019
- Published by Elsevier in Bioorganic Chemistry
- Vol. 87, 720-727
Design, synthesis and evaluation of a novel metal chelator as multifunctional agents for the treatment of Alzheimer’s disease
- 30 April 2018
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 92 (3) , 1597-1609
Design, synthesis, and biological evaluation of structurally constrained hybrid analogues containing ropinirole moiety as a novel class of potent and selective dopamine D3 receptor ligands
Two series of hybrid analogues were designed, synthesized, and evaluated as a novel class of selective ligands for the dopamine D3 receptor. Binding affinities of target compounds were determined (using the method of radioligand binding assay). Compared to comparator agent BP897, compounds 2a and 2c were found to demonstrate a considerable binding affinity and selectivity for D3 receptor, and especially compound 2h was similarly potent and more selective D3R ligand than BP897, a positive reference. Thus, they may provide valuable information for the discovery and development of highly potent dopamine D3 receptor ligands with outstanding selectivity.
- 30 April 2018
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 92 (3) , 1597-1609
Design, synthesis, and biological evaluation of structurally constrained hybrid analogues containing ropinirole moiety as a novel class of potent and selective dopamine D3 receptor ligands
Two series of hybrid analogues were designed, synthesized, and evaluated as a novel class of selective ligands for the dopamine D3 receptor. Binding affinities of target compounds were determined (using the method of radioligand binding assay). Compared to comparator agent BP897, compounds 2a and 2c were found to demonstrate a considerable binding affinity and selectivity for D3 receptor, and especially compound 2h was similarly potent and more selective D3R ligand than BP897, a positive reference. Thus, they may provide valuable information for the discovery and development of highly potent dopamine D3 receptor ligands with outstanding selectivity.
- 1 April 2018
- Published by Elsevier in Bioorganic Chemistry
- Vol. 77, 125-135
Design, synthesis and biological evaluation of bitopic arylpiperazine-hexahydro-pyrazinoquinolines as preferential dopamine D3 receptor ligands
- 1 April 2018
- Published by Elsevier in Bioorganic Chemistry
- Vol. 77, 125-135
Design, synthesis and biological evaluation of bitopic arylpiperazine-hexahydro-pyrazinoquinolines as preferential dopamine D3 receptor ligands
- 14 January 2016
- Published by Springer Nature in Journal of Sol-Gel Science and Technology
- Vol. 77 (2) , 516-520
Novel yolk–shell structured silica nanosphere with a movable silica-coated gold core
- 14 January 2016
- Published by Springer Nature in Journal of Sol-Gel Science and Technology
- Vol. 77 (2) , 516-520
Novel yolk–shell structured silica nanosphere with a movable silica-coated gold core